As new ICH GCP draft guidelines now require root cause analysis, novel methods for risk analysis and triage must be adopted in drug development.
Clara Heering
Advertisement
Articles by Clara Heering
Advertisement
Latest Updated Articles
What Errors Do We Miss in Clinical Trials?Published: March 8th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5
